|
1
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmstrom PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Robb T, Reid G and Blenkiron C: Exploiting
microRNAs As cancer therapeutics. Target Oncol. 12:163–178. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gandellini P, Doldi V and Zaffaroni N:
microRNAs as players and signals in the metastatic cascade:
Implications for the development of novel anti-metastatic
therapies. Semin Cancer Biol. 44:132–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wong CM, Tsang FH and Ng IO: Non-coding
RNAs in hepatocellular carcinoma: Molecular functions and
pathological implications. Nat Rev Gastroenterol Hepatol.
15:137–151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-145 downregulates
SIP1-expression but differentially regulates proliferation,
migration, invasion and Wnt signaling in SW480 and SW620 cells. J
Cell Biochem. 119:2022–2035. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan Y, Ma X, Li H, Gao Y, Huang Q, Zhang
Y, Bao X, Du Q, Luo G, Liu K, et al: miR-122 promotes metastasis of
clear-cell renal cell carcinoma by downregulating Dicer. Int J
Cancer. 142:547–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv C, Li F, Li X, Tian Y, Zhang Y, Sheng
X, Song Y, Meng Q, Yuan S, Luan L, et al: MiR-31 promotes
mammary stem cell expansion and breast tumorigenesis by suppressing
Wnt signaling antagonists. Nat Commun. 8:10362017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G
and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xin C, Zhang H and Liu Z: miR-154
suppresses colorectal cancer cell growth and motility by targeting
TLR2. Mol Cell Biochem. 387:271–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu H, Fei D, Zong S and Fan Z:
MicroRNA-154 inhibits growth and invasion of breast cancer cells
through targeting E2F5. Am J Transl Res. 8:2620–2630.
2016.PubMed/NCBI
|
|
14
|
Pang X, Huang K, Zhang Q, Zhang Y and Niu
J: miR-154 targeting ZEB2 in hepatocellular carcinoma functions as
a potential tumor suppressor. Oncol Rep. 34:3272–3279. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao X, Ji Z, Xie Y, Liu G and Li H:
MicroRNA-154 as a prognostic factor in bladder cancer inhibits
cellular malignancy by targeting RSF1 and RUNX2. Oncol Rep.
38:2727–2734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karvela M, Baquero P, Kuntz EM,
Mukhopadhyay A, Mitchell R, Allan EK, Chan E, Kranc KR, Calabretta
B, Salomoni P, et al: ATG7 regulates energy metabolism,
differentiation and survival of Philadelphia-chromosome-positive
cells. Autophagy. 12:936–948. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kimmelman AC and White E: Autophagy and
tumor metabolism. Cell Metab. 25:1037–1043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo JY, Karsli-Uzunbas G, Mathew R, Aisner
SC, Kamphorst JJ, Strohecker AM, Chen G, Price S, Lu W, Teng X, et
al: Autophagy suppresses progression of K-ras-induced lung tumors
to oncocytomas and maintains lipid homeostasis. Genes Dev.
27:1447–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu J, Li Y, Tian Z, Hua X, Gu J, Li J,
Liu C, Jin H, Wang Y, Jiang G, et al: ATG7 overexpression is
crucial for tumorigenic growth of bladder cancer in vitro and in
vivo by targeting the ETS2/miRNA196b/FOXO1/p27 Axis. Mol Ther
Nucleic Acids. 7:299–313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao AM, Zhang XY, Hu JN and Ke ZP:
Apigenin sensitizes hepatocellular carcinoma cells to doxorubic
through regulating miR-520b/ATG7 axis. Chem Biol Interact.
280:45–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu DN, Jiang MJ, Mei Z, Dai JJ, Dai CY,
Fang C, Huang Q and Tian L: microRNA-7 impairs autophagy-derived
pools of glucose to suppress pancreatic cancer progression. Cancer
Lett. 400:69–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187.e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng Y, Huo G, Mo Y, Wang W and Chen H:
MIR137 regulates starvation-induced autophagy by targeting ATG7. J
Mol Neurosci. 56:815–821. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Margulis V, Shariat SF, Ashfaq R,
Sagalowsky AI and Lotan Y: Ki-67 is an independent predictor of
bladder cancer outcome in patients treated with radical cystectomy
for organ-confined disease. Clin Cancer Res. 12:7369–7373. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Zhao E, Yu Y, Geng B, Zhang W and
Li X: MiR-216a exerts tumor-suppressing functions in renal cell
carcinoma by targeting TLR4. Am J Cancer Res. 8:476–488.
2018.PubMed/NCBI
|
|
28
|
Xu M, Li J, Wang X, Meng S, Shen J, Wang
S, Xu X, Xie B, Liu B and Xie L: MiR-22 suppresses
epithelial-mesenchymal transition in bladder cancer by inhibiting
Snail and MAPK1/Slug/vimentin feedback loop. Cell Death Dis.
9:2092018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Juracek J, Peltanova B, Dolezel J, Fedorko
M, Pacik D, Radova L, Vesela P, Svoboda M, Slaby O and Stanik M:
Genome-wide identification of urinary cell-free microRNAs for
non-invasive detection of bladder cancer. J Cell Mol Med.
22:2033–2038. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen HQ and Gao D: Inhibitory effect of
microRNA-154 targeting WHSC1 on cell proliferation of human skin
squamous cell carcinoma through mediating the P53 signaling
pathway. Int J Biochem Cell Biol. 100:22–29. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun S, Wang Z, Tang F, Hu P, Yang Z, Xue
C, Gong J, Shi L and Xie C: ATG7 promotes the tumorigenesis of lung
cancer but might be dispensable for prognosis predication: A
clinicopathologic study. Onco Targets Ther. 9:4975–4981. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu Y, Zhang J, Jin Y, Yang Y, Shi J, Chen
F, Han S, Chu P, Lu J, Wang H, et al: MiR-20a-5p suppresses tumor
proliferation by targeting autophagy-related gene 7 in
neuroblastoma. Cancer Cell Int. 18:52018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levy J, Cacheux W, Bara MA, L'Hermitte A,
Lepage P, Fraudeau M, Trentesaux C, Lemarchand J, Durand A, Crain
AM, et al: Intestinal inhibition of Atg7 prevents tumour initiation
through a microbiome-influenced immune response and suppresses
tumour growth. Nat Cell Biol. 17:1062–1073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Piya S, Kornblau SM, Ruvolo VR, Mu H,
Ruvolo PP, McQueen T, Davis RE, Hail N Jr, Kantarjian H, Andreeff
M, et al: Atg7 suppression enhances chemotherapeutic agent
sensitivity and overcomes stroma-mediated chemoresistance in acute
myeloid leukemia. Blood. 128:1260–1269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiang L, Sample A, Shea CR, Soltani K,
Macleod KF and He YY: Autophagy gene ATG7 regulates
ultraviolet radiation-induced inflammation and skin tumorigenesis.
Autophagy. 13:2086–2103. 2017. View Article : Google Scholar : PubMed/NCBI
|
